Bioseparation Screening Columns
For ChromSpeed¢â and MabSpeeed¢â, Mitsubishi Chemical Corporation is pleased to offer pre-packed screening columns.
Introduction
Commercial purifications in large scale begin at a small scale in methods development. In some cases, the developers and researchers wish to use media to pack their initial small columns. This case allows one to experience how the media can be handled physically and chemically, and one can utilize the knowledge later on during the scale-up periods. In other cases, the due to the speed and convenience of having a pre-packed column for media evaluation is necessary. These screening columns, available in sizes listed in Table 1, are suitable for evaluating different types of MabSpeed¢â*, shown in Table 2, and ChromSpeed¢â, shown in Table 3 for developing the purification conditions of biological target molecules such as proteins or nucleic acids. The screening columns are available in two column volumes of 1mL and 5mL.
Highlights of screening columns
-Packed with ChromSpeed¢â for ion exchange media and with MabSpeed¢â for affinity chromatography media.
-Low cost, efficient, and alternative to self packing.
-Easy connections with AKTA¨Ï, FPLC¨Ï, and HPLC
-Offered in mixed or single chemistry packages of 4 or 5 columns
Screening
A ChromSpeed¢â screening column is available in two different particle sizes and four different functional groups. A MabSpeed¢â screening column is available in two different particle sizes. Optimal selection of a particular media could involve screening of several media.
Table 1. Sizes and dimensions available for the screening columns.
|
Volume |
Dimension |
ChromSpeed™ |
1 mL |
7 mm ID ¡¿ 26 mm |
MabSpeed™ |
5 mL |
15.7 mm ID ¡¿ 26 mm |
Table 2. Product line-up of MabSpeed¢â affinity chromatography media*
|
Type of ligand |
Particle diameter (¥ìm) |
DBC*** (g/L-media) |
rP102 |
Protein-A |
45 |
24 |
rP111 |
35 |
33 |
rP202** |
45 |
TBA |
*Screening columns of MabSpeed¢â affinity chromatography media are available upon request..
**MabSpeed¢â rP202 columns are available in Asia and will be available in other regions in the end of 2016..
***10% breakthrough, ¥ã-globulin, r.t. 3min
Table 3. Product line-up of ChromSpeed¢â ion exchange media
|
Functional group |
Particle diameter (¥ìm) |
Ion exchange capacity (eq/L-media) |
Human ¥ã-globulin SBC (g/L-media) |
S103
S101
|
-SO3- |
60
60
|
0.09
0.08
|
125
140
|
Q103
Q101
|
-N+(CH3)3 |
60
30
|
0.08
0.08
|
124
130
|
CM103
CM101
|
-COO- |
60
30
|
0.11
0.1
|
114
120
|
Q103
Q101
|
-N+H(CH3)2 |
60
30
|
0.13
0.11
|
81
98
|
ChromSpeed¢â ion exchange media separates molecules based on the ionic interaction of the molecules with the charged support. The net surface charge of proteins is dependent on the pH and ionic strength of the mobile phases. The development of optimal chromatography conditions requires knowledge of both the protein¡¯s pI and the pKa of the ion exchange media. In bio-purification or purifications of biologics, ChromSpeed¢â can be used either in ¡°bind/ elute mode¡± and/ or in ¡°flow-through mode.¡± Ion exchange media should be selected according to the properties of the feedstock and the objective of the process steps. ChromSpeed¢â media are designed for such a large molecules with large pore sizes, mainly dominated in the range of 500 to 1000 A, offering large binding capacity. Some of typical applications is shown in Figure 1 and 2 as well as Figure 3.
Laboratory benchtop purifications
MabSpeed¢â rP111 was used for the purification of a monoclonal antibody from CHO cell culture supernatant with a concentration of 0.5 mg/mL at 3 minutes residence time in a 15 cm bed height column. Consecutively, the processed fluid was purified with ChromSpeed¢â S101 and ChromSpeed¢â Q101, as a flow of Figure 4 shows, and the intermediate and final products were analyzed with regard to yield, dimers, aggregates, Protein A carry over, and Host Cell Proteins (HCP) as shown in the following Table 4.
Table 4. Representative data analyzed at each process described in Figure 4.
|
Accumulated Yield (%) |
Dimers & aggregates (%)* |
Protein-A (ppm)** |
HCP (ppm)** |
Starting Material |
100 |
- |
- |
35717 |
rP111 |
98 |
< 0.5% |
4.4 |
3.1 |
S101 |
90 |
< 0.5% |
2.6 |
< 0.5 |
Q101 |
88 |
< 0.5% |
2.4 |
< 0.5 |
*Data measured by size exclusion HPLC method.
**HCP and Protein-A concentration were measured by typical ELIZA kit, available on market.
Figure 4. Process flow diagram of purification of a monoclonal antibody from CHO cell culture supernatant.
Related Data Sheets:
MabSpeed¢â rP102 & rP111: No. 03-07-C-0101
MabSpeed¢â rP202 : No. 03-07-C-0201
ChromSpeed¢â S101 & S103 : No. 03-02-C-0101
ChromSpeed¢â Q101 & S103 : No. 03-04-C-0101
ChromSpeed¢â CM101 & CM103 : No. 03-03-C-0101
ChromSpeed¢â DA101 & DA103 : No. 03-05-C-0101
Ordering information
Screening column: volume |
Contents |
Unit |
Part Number |
ChromSpeed™ S103 |
1 |
mL |
5 columns |
set |
7-103-01 |
ChromSpeed™ Q103 |
7-103-00 |
ChromSpeed™ CM103 |
7-103-03 |
ChromSpeed™ DA103 |
7-103-02 |
ChromSpeed™ 103Kit |
each (total of 4) |
7-103-04 |
ChromSpeed™ S103 |
5 |
mL |
5 columns |
set |
7-104-01 |
ChromSpeed™ Q103 |
7-104-00 |
ChromSpeed™ CM103 |
7-104-03 |
ChromSpeed™ DA103 |
7-104-02 |
ChromSpeed™ 103Kit |
each (total of 4) |
7-104-04 |
ChromSpeed™ S101 |
1 |
mL |
5 columns |
set |
7-101-01 |
ChromSpeed™ Q101 |
7-101-00 |
ChromSpeed™ CM101 |
7-101-03 |
ChromSpeed™ DA101 |
7-101-02 |
ChromSpeed™ 101Kit |
each (total of 4) |
7-101-04 |
ChromSpeed™ S101 |
5 |
mL |
5 columns |
set |
7-102-01 |
ChromSpeed™ Q101 |
7-102-00 |
ChromSpeed™ CM101 |
7-102-03 |
ChromSpeed™ DA101 |
7-102-02 |
ChromSpeed™ 101Kit |
each (total of 4) |
7-102-04 |